• Users Online: 202
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2021  |  Volume : 7  |  Issue : 1  |  Page : 3-7

Implications of the use of hydroxychloroquine on cardioactive drugs


1 Department of Cardiology, PGIMER, Chandigarh, Punjab, India
2 Department of Cardiology, Fortis Hospital, Mohali, Punjab, India
3 Department of Cardiology, VMMC and Safdarjung Hospital, New Delhi, India

Correspondence Address:
Sourabh Agstam
Department of Cardiology, VMMC and Safdarjung Hospital, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jpcs.jpcs_84_20

Rights and Permissions

Hydroxychloroquine (HCQ) is a relatively safe drug, and has been emerged as one of the treatment options for the management of COVID-19. This review is from the viewpoint of cardiologists, and it covers the pharmacokinetics, pharmacodynamics, and mechanism of drug interaction of HCQ with the commonly used cardioactive drugs.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3246    
    Printed54    
    Emailed0    
    PDF Downloaded157    
    Comments [Add]    

Recommend this journal